{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:16:01Z","timestamp":1783120561656,"version":"3.54.6"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:00Z","timestamp":1625184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["18K15534"],"award-info":[{"award-number":["18K15534"]}]},{"name":"JSPS KAKENHI","award":["18H02756"],"award-info":[{"award-number":["18H02756"]}]},{"name":"JSPS KAKENHI","award":["18K07620"],"award-info":[{"award-number":["18K07620"]}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18dk0307081h0001"],"award-info":[{"award-number":["18dk0307081h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18dm0107100h0003"],"award-info":[{"award-number":["18dm0107100h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18dk0307062h0003"],"award-info":[{"award-number":["18dk0307062h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","award":["JP20gm0010004h9904"],"award-info":[{"award-number":["JP20gm0010004h9904"]}],"id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Lysophosphatidic acid (LPA) is involved in numerous biological processes, including neurodevelopment, chronic inflammation, and immunologic response in the central nervous system. Autotaxin (ATX) is a secreted enzyme that produces LPA from lysophosphatidylcholine (LPC). Previous studies have demonstrated decreased protein levels of ATX in cerebrospinal fluid (CSF) of patients with major depressive disorder (MDD). Based on those studies, the current study investigated the levels of lysophospholipids species including LPA and related metabolic enzymes, in CSF of patients with MDD and schizophrenia (SCZ).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The levels of lysophospholipids species and related metabolic enzymes were measured with either liquid chromatography-tandem mass spectrometry or enzyme-linked immunosorbent assay. Japanese patients were diagnosed with DSM-IV-TR. CSF was obtained from age- and sex-matched healthy controls (n\u2009=\u200927) and patients with MDD (n\u2009=\u200926) and SCZ (n\u2009=\u200927).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of all lysophospholipids species, the levels of LPA 22:6 (LPA - docosahexaenoic acid) were significantly lower in patients with MDD and SCZ than in healthy controls. These levels were negatively correlated with several clinical symptomatic scores of MDD, but not those of SCZ. In addition, the levels of LPA 22:6 were significantly correlated with the levels of LPC 22:6 among all 3 groups. On the other hand, the levels of LPA 22:6 were not correlated with ATX activity in patients with MDD and SCZ.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The lower levels of LPA 22:6 in patients with MDD and SCZ suggest an abnormality of LPA 22:6 metabolism. In addition, several depressive symptoms in patients with MDD were significantly associated with the lower levels of LPA 22:6, suggesting an involvement of LPA 22:6 in the pathophysiology of MDD.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ijnp\/pyab044","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T15:32:19Z","timestamp":1625067139000},"page":"948-955","source":"Crossref","is-referenced-by-count":18,"title":["Reduced Cerebrospinal Fluid Levels of Lysophosphatidic Acid Docosahexaenoic Acid in Patients With Major Depressive Disorder and Schizophrenia"],"prefix":"10.1093","volume":"24","author":[{"given":"Wataru","family":"Omori","sequence":"first","affiliation":[{"name":"Division of Psychiatry and Neuroscience, Institute for Clinical Research, National Hospital Organization (NHO) Kure Medical Center and Chugoku Cancer Center, Kure, Hiroshima, Japan"},{"name":"Department of Psychiatry, NHO Kure Medical Center and Chugoku Cancer Center, Kure, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniyuki","family":"Kano","sequence":"additional","affiliation":[{"name":"Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan"},{"name":"AMED-LEAP, Japan Agency for Medical Research and Development, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Hattori","sequence":"additional","affiliation":[{"name":"Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan"},{"name":"Medical Genome Center, National Center of Neurology and Psychiatry, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Kajitani","sequence":"additional","affiliation":[{"name":"Division of Psychiatry and Neuroscience, Institute for Clinical Research, National Hospital Organization (NHO) Kure Medical Center and Chugoku Cancer Center, Kure, Hiroshima, Japan"},{"name":"Department of Neuropsychiatry, Faculty of Life Science, Kumamoto University, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mami","family":"Okada-Tsuchioka","sequence":"additional","affiliation":[{"name":"Division of Psychiatry and Neuroscience, Institute for Clinical Research, National Hospital Organization (NHO) Kure Medical Center and Chugoku Cancer Center, Kure, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuken","family":"Boku","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Faculty of Life Science, Kumamoto University, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kunugi","sequence":"additional","affiliation":[{"name":"Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan"},{"name":"Department of Psychiatry, Teikyo University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junken","family":"Aoki","sequence":"additional","affiliation":[{"name":"Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan"},{"name":"AMED-LEAP, Japan Agency for Medical Research and Development, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9962-8444","authenticated-orcid":false,"given":"Minoru","family":"Takebayashi","sequence":"additional","affiliation":[{"name":"Division of Psychiatry and Neuroscience, Institute for Clinical Research, National Hospital Organization (NHO) Kure Medical Center and Chugoku Cancer Center, Kure, Hiroshima, Japan"},{"name":"Department of Neuropsychiatry, Faculty of Life Science, Kumamoto University, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,2]]},"reference":[{"key":"2021120815382410200_CIT0001","volume-title":"Diagnostic and statistical manual of mental disorders: DSM-IV-TR","author":"American Psychiatric Association","year":"2000","edition":"4th ed."},{"key":"2021120815382410200_CIT0002","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1002\/glia.22572","article-title":"Lysophosphatidic acid (LPA) and its receptor, LPA1, influence embryonic schwann cell migration, myelination, and cell-to-axon segregation","volume":"61","author":"Anliker","year":"2013","journal-title":"Glia"},{"key":"2021120815382410200_CIT0003","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1749-6632.2000.tb06557.x","article-title":"Quantitative analysis of lysophosphatidic acid in human blood fractions","volume":"905","author":"Baker","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"2021120815382410200_CIT0004","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.plipres.2015.02.001","article-title":"Autotaxin, a secreted lysophospholipase D, as a promising therapeutic target in chronic inflammation and cancer","volume":"58","author":"Barbayianni","year":"2015","journal-title":"Prog Lipid Res"},{"key":"2021120815382410200_CIT0005","doi-asserted-by":"crossref","first-page":"272","DOI":"10.7555\/JBR.30.20150058","article-title":"Recent advances in targeting the autotaxin-lysophosphatidate-lipid phosphate phosphatase axis in vivo","volume":"30","author":"Benesch","year":"2016","journal-title":"J Biomed Res"},{"key":"2021120815382410200_CIT0006","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3390\/nu10050620","article-title":"Comparison of the incorporation of DHA in circulatory and neural tissue when provided as Triacylglycerol (TAG), Monoacylglycerol (MAG) or Phospholipids (PL) provides new insight into fatty acid bioavailability","volume":"10","author":"Destaillats","year":"2018","journal-title":"Nutrients"},{"key":"2021120815382410200_CIT0007","doi-asserted-by":"crossref","first-page":"e01699","DOI":"10.1016\/j.heliyon.2019.e01699","article-title":"Lysophosphatidic acid levels in cerebrospinal fluid and plasma samples in patients with major depressive disorder","volume":"5","author":"Gotoh","year":"2019","journal-title":"Heliyon"},{"key":"2021120815382410200_CIT0008","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.psychres.2019.01.052","article-title":"Levels of lysophosphatidic acid in cerebrospinal fluid and plasma of patients with schizophrenia","volume":"273","author":"Gotoh","year":"2019","journal-title":"Psychiatry Res"},{"key":"2021120815382410200_CIT0009","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jad.2016.08.011","article-title":"Dietary n-3 PUFA, fish consumption and depression: a systematic review and meta-analysis of observational studies","volume":"205","author":"Grosso","year":"2016","journal-title":"J Affect Disord"},{"key":"2021120815382410200_CIT0010","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.mcn.2003.09.001","article-title":"LPA1 receptor-deficient mice have phenotypic changes observed in psychiatric disease","volume":"24","author":"Harrison","year":"2003","journal-title":"Mol Cell Neurosci"},{"key":"2021120815382410200_CIT0011","doi-asserted-by":"crossref","first-page":"11412","DOI":"10.1038\/srep11412","article-title":"Increased cerebrospinal fluid fibrinogen in major depressive disorder","volume":"5","author":"Hattori","year":"2015","journal-title":"Sci Rep"},{"key":"2021120815382410200_CIT0012","doi-asserted-by":"crossref","first-page":"9144","DOI":"10.1038\/s41598-019-45742-7","article-title":"Lysophosphatidic acids and their substrate lysophospholipids in cerebrospinal fluid as objective biomarkers for evaluating the severity of lumbar spinal stenosis","volume":"9","author":"Hayakawa","year":"2019","journal-title":"Sci Rep"},{"key":"2021120815382410200_CIT0013","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/pcn.12275","article-title":"Psychotropic dose equivalence in Japan","volume":"69","author":"Inada","year":"2015","journal-title":"Psychiatry Clin Neurosci"},{"key":"2021120815382410200_CIT0014","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/ijnp\/pyz005","article-title":"Reduced serum and cerebrospinal fluid levels of autotaxin in major depressive disorder","volume":"22","author":"Itagaki","year":"2019","journal-title":"Int J Neuropsychopharmacol"},{"key":"2021120815382410200_CIT0015","doi-asserted-by":"crossref","first-page":"27364","DOI":"10.1074\/jbc.M116.753871","article-title":"Identification of lysophosphatidic acid receptor 1 in astroglial cells as a target for glial cell line-derived neurotrophic factor expression induced by antidepressants","volume":"291","author":"Kajitani","year":"2016","journal-title":"J Biol Chem"},{"key":"2021120815382410200_CIT0016","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.bbalip.2019.02.008","article-title":"An accurate and versatile method for determining the acyl group-introducing position of lysophospholipid acyltransferases","volume":"1864","author":"Kawana","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"2021120815382410200_CIT0017","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/ATVBAHA.114.304748","article-title":"Possible involvement of minor lysophospholipids in the increase in plasma lysophosphatidic acid in acute coronary syndrome","volume":"35","author":"Kurano","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2021120815382410200_CIT0018","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1385\/JMN:16:2-3:201","article-title":"Lysophosphatidylcholine as a preferred carrier form of docosahexaenoic acid to the brain","volume":"16","author":"Lagarde","year":"2001","journal-title":"J Mol Neurosci"},{"key":"2021120815382410200_CIT0019","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41398-019-0515-5","article-title":"Efficacy of omega-3 PUFAs in depression: a meta-analysis","volume":"9","author":"Liao","year":"2019","journal-title":"Transl Psychiatry"},{"key":"2021120815382410200_CIT0020","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1176\/appi.ajp.160.5.996","article-title":"A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression","volume":"160","author":"Marangell","year":"2003","journal-title":"Am J Psychiatry"},{"key":"2021120815382410200_CIT0021","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3945\/jn.109.113233","article-title":"DHA deficiency and prefrontal cortex neuropathology in recurrent affective disorders","volume":"140","author":"McNamara","year":"2010","journal-title":"J Nutr"},{"key":"2021120815382410200_CIT0022","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biopsych.2006.08.026","article-title":"Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder","volume":"62","author":"McNamara","year":"2007","journal-title":"Biol Psychiatry"},{"key":"2021120815382410200_CIT0023","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.schres.2006.11.027","article-title":"Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medications","volume":"91","author":"McNamara","year":"2007","journal-title":"Schizophr Res"},{"key":"2021120815382410200_CIT0024","doi-asserted-by":"crossref","first-page":"e541","DOI":"10.1038\/tp.2015.33","article-title":"LPA signaling initiates schizophrenia-like brain and behavioral changes in a mouse model of prenatal brain hemorrhage","volume":"5","author":"Mirendil","year":"2015","journal-title":"Transl Psychiatry"},{"key":"2021120815382410200_CIT0025","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.euroneuro.2008.04.011","article-title":"A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder","volume":"18","author":"Mischoulon","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"2021120815382410200_CIT0026","doi-asserted-by":"crossref","first-page":"e1077","DOI":"10.1038\/tp.2017.24","article-title":"maLPA1-null mice as an endophenotype of anxious depression","volume":"7","author":"Moreno-Fern\u00e1ndez","year":"2017","journal-title":"Transl Psychiatry"},{"key":"2021120815382410200_CIT0027","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cca.2007.10.005","article-title":"Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation","volume":"388","author":"Nakamura","year":"2008","journal-title":"Clin Chim Acta"},{"key":"2021120815382410200_CIT0028","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nature13241","article-title":"Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid","volume":"509","author":"Nguyen","year":"2014","journal-title":"Nature"},{"key":"2021120815382410200_CIT0029","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1194\/jlr.D048439","article-title":"Separation and quantification of 2-acyl-1-lysophospholipids and 1-acyl-2-lysophospholipids in biological samples by LC-MS\/MS","volume":"55","author":"Okudaira","year":"2014","journal-title":"J Lipid Res"},{"key":"2021120815382410200_CIT0030","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1124\/jpet.116.236455","article-title":"LPA1 mediates antidepressant-induced ERK1\/2 signaling and protection from oxidative stress in glial cells","volume":"359","author":"Olianas","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"2021120815382410200_CIT0031","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1440-1819.2005.01408.x","article-title":"Reliability and validity of Japanese version of the Mini-International Neuropsychiatric Interview","volume":"59","author":"Otsubo","year":"2005","journal-title":"Psychiatry Clin Neurosci"},{"key":"2021120815382410200_CIT0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0090-6980(01)00110-1","article-title":"Lysophosphatidic acid synthesis and release","volume":"64","author":"Pag\u00e8s","year":"2001","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"2021120815382410200_CIT0033","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1194\/jlr.R046391","article-title":"Autotaxin: structure-function and signaling","volume":"55","author":"Perrakis","year":"2014","journal-title":"J Lipid Res"},{"key":"2021120815382410200_CIT0034","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/ijms19071827","article-title":"Autotaxin(-)Lysophosphatidic acid signaling in Alzheimer\u2019s disease","volume":"19","author":"Ramesh","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2021120815382410200_CIT0035","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11064-005-2611-6","article-title":"Neurochemical changes in LPA1 receptor deficient mice\u2013a putative model of schizophrenia","volume":"30","author":"Roberts","year":"2005","journal-title":"Neurochem Res"},{"key":"2021120815382410200_CIT0036","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/j.1460-9568.2004.03265.x","article-title":"Functional importance of Ca2+-activated K+ channels for lysophosphatidic acid-induced microglial migration","volume":"19","author":"Schilling","year":"2004","journal-title":"Eur J Neurosci"},{"key":"2021120815382410200_CIT0037","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.plefa.2010.07.001","article-title":"Polyunsaturated fatty acids deficits are associated with psychotic state and negative symptoms in patients with schizophrenia","volume":"83","author":"Sethom","year":"2010","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"2021120815382410200_CIT0038","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"2021120815382410200_CIT0039","doi-asserted-by":"crossref","first-page":"11263","DOI":"10.1038\/s41598-017-11766-0","article-title":"Dietary docosahexaenoic acid (DHA) as lysophosphatidylcholine, but not as free acid, enriches brain DHA and improves memory in adult mice","volume":"7","author":"Sugasini","year":"2017","journal-title":"Sci Rep"},{"key":"2021120815382410200_CIT0040","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1017\/S1461145705006085","article-title":"Decreased levels of whole blood glial cell line-derived neurotrophic factor (GDNF) in remitted patients with mood disorders","volume":"9","author":"Takebayashi","year":"2006","journal-title":"Int J Neuropsychopharmacol"},{"key":"2021120815382410200_CIT0041","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.cell.2009.06.050","article-title":"Synaptic PRG-1 modulates excitatory transmission via lipid phosphate-mediated signaling","volume":"138","author":"Trimbuch","year":"2009","journal-title":"Cell"},{"key":"2021120815382410200_CIT0042","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1515\/revneuro-2016-0063","article-title":"Role of glial cell line-derived neurotrophic factor in the pathogenesis and treatment of mood disorders","volume":"28","author":"Tsybko","year":"2017","journal-title":"Rev Neurosci"},{"key":"2021120815382410200_CIT0043","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.neuron.2010.12.023","article-title":"Epigenetic status of Gdnf in the ventral striatum determines susceptibility and adaptation to daily stressful events","volume":"69","author":"Uchida","year":"2011","journal-title":"Neuron"},{"key":"2021120815382410200_CIT0044","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1083\/jcb.200204026","article-title":"Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production","volume":"158","author":"Umezu-Goto","year":"2002","journal-title":"J Cell Biol"},{"key":"2021120815382410200_CIT0045","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.3748\/wjg.v24.i36.4132","article-title":"Production of extracellular lysophosphatidic acid in the regulation of adipocyte functions and liver fibrosis","volume":"24","author":"Yang","year":"2018","journal-title":"World J Gastroenterol"},{"key":"2021120815382410200_CIT0046","doi-asserted-by":"crossref","first-page":"99ra87","DOI":"10.1126\/scitranslmed.3002095","article-title":"Lysophosphatidic acid signaling may initiate fetal hydrocephalus","volume":"3","author":"Yung","year":"2011","journal-title":"Sci Transl Med"},{"key":"2021120815382410200_CIT0047","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.neuron.2015.01.009","article-title":"Lysophosphatidic acid signaling in the nervous system","volume":"85","author":"Yung","year":"2015","journal-title":"Neuron"}],"container-title":["International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ijnp\/advance-article-pdf\/doi\/10.1093\/ijnp\/pyab044\/39457053\/pyab044.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijnp\/article-pdf\/24\/12\/948\/41649967\/pyab044.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijnp\/article-pdf\/24\/12\/948\/41649967\/pyab044.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T13:29:07Z","timestamp":1699190947000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article\/24\/12\/948\/6313199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,2]]},"references-count":47,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,7,2]]},"published-print":{"date-parts":[[2021,12,8]]}},"URL":"https:\/\/doi.org\/10.1093\/ijnp\/pyab044","relation":{},"ISSN":["1461-1457","1469-5111"],"issn-type":[{"value":"1461-1457","type":"print"},{"value":"1469-5111","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,1]]},"published":{"date-parts":[[2021,7,2]]}}}